During the past decade, ISIS Clinica Especializada conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 13 clinical trials were completed, i.e. on average, 433.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ISIS Clinica Especializada" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Helsinn Healthcare SA" with 2 trials sponsored, "Agennix" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "CTI BioPharma" with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ISIS Clinica Especializada" #1 collaborator was "Parexel" with 2 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "CIMAB (Cuba)" with 1 trials as a collaborator and "Eurofarma Laboratorios S.A." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "ISIS Clinica Especializada" are "Breast Cancer" (3 trials), "Chemotherapy-Induced Nausea and Vomiting" (2 trials), "Melanoma" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Non-small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "ISIS Clinica Especializada" in a lesser frequency.

Most popular intervention types in "ISIS Clinica Especializada" are "Drug" (22 trials), "Biological" (4 trials), "Other" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Erlotinib" (3 trials), "Paclitaxel" (3 trials), "Trastuzumab" (3 trials) and "Capecitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "ISIS Clinica Especializada" are 18 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "ISIS Clinica Especializada". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in ISIS Clinica Especializada, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ISIS Clinica Especializada, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

ISIS Clinica Especializada has several departments that took part in Clinical trials: "Centro Modelo de Cardiologia" - 5 trials, "Instituto de Asistencia Reumatologica Integral" - 4 trials